Barbara J. McNeil, M.D., Ph.D., Chair
Dr. McNeil is the Ridley Watts Professor and founding Head of the Department of Health Care Policy at Harvard Medical School. She is also a Professor of Radiology at Harvard Medical School and at Brigham and Women's Hospital.  Dr. McNeil's research activities focus on several areas. These include the development and implementation of quality measures for chronic cardiac diseases, the role of financial incentives and managerial practices in assuring quality, and the evaluation of new technologies in terms of their costs and effectiveness. Work in these areas has been funded primarily by grants from the Agency for Healthcare Research and Quality, the National Cancer Institute, and the Department of Veterans Affairs. Her most recent project involved comparing the quality of care for veterans with cardiac disease to the care provided to Medicare beneficiaries seen in private settings. Its report led Secretary Anthony Prinicipi to introduce many changes in the care of veterans with cardiac disease. Dr. McNeil sat on the blue ribbon committee evaluating these changes. She is currently also working with the national Blue Cross Blue Shield Association in evaluating the effectiveness of various interventions its plans have undertaken to increase quality and/or decrease cost.  Dr. McNeil received her A.B. degree from Emmanuel College, her M.D. from Harvard Medical School, and her Ph.D. from Harvard University. She is a member of the Institute of Medicine of the National Academy of Sciences (where she is Chair of its Board of Health Care Services) and the American Academy of Arts and Sciences. Dr. McNeil is also a member of the Blue Cross Technology Evaluation Commission (TEC), the Medicare Coverage Advisory Committee, and the Council for Performance Measurement for the JCAHO. Previously Dr. McNeil served as a member of the Prospective Payment Assessment Commission and the Publications Committee of the New England Journal of Medicine.

Harold C. Sox, M.D., M.A.C.P., Vice Chair
Hal Sox, Editor, Annals of Internal Medicine, received his medical degree from Harvard Medical School in 1966. After serving as a medical intern and resident at Massachusetts General Hospital, he spent two years doing research in immunology at the National Institutes of Health and three years at Dartmouth Medical School. There he served as chief medical resident and began his studies of medical decision-making. Sox then spent fifteen years on the faculty of Stanford University School of Medicine where he served as chief of the division of general internal medicine and as a director of ambulatory care at the Palo Alto Veterans Administration Medical Center.  In 1988, he returned to Dartmouth to chair the department of medicine. He was the Joseph M. Huber Professor of Medicine and chair of the department of medicine at Dartmouth-Hitchcock Medical Center until 2001 when he became Editor of Annals of Internal Medicine.  Sox has led national committees that have shaped clinical, educational, and public policy in the United States. He has served as chair of the U.S. Preventive Services Task Force, the Medicare Coverage Advisory Committee, the Institute of Medicine Committee to Study HIV Transmission Through Blood Products, and the Institute of Medicine Committee on Health Effects of Exposures in the Persian Gulf War. He is a member of the Institute of Medicine of the National Academies.  A general internist, Sox has also been a leader of internal medicine nationally. He served as president of the American College of Physicians from April 1998 to April 1999.  Sox was an associate editor of Scientific American Medicine and has served on the editorial boards of three medical journals, including The New England Journal of Medicine. He is the author of ten books and many book chapters and journal articles. Sox is the principal author of Medical Decision Making and was editor of both the first and second editions of Common Diagnostic Tests, a groundbreaking evaluation of commonly used medical tests, first published in 1987. In his lifetime of research and writing, Sox has explored issues such as technology assessment, medical decision-making, disease prevention and health promotion, cost effectiveness analysis, physicians' and patients' risk preferences, and medical education.

Allen Daniels, LISW, Ed.D.
Allen Daniels, EdD, is professor of clinical psychiatry and executive vice chair in the Department of Psychiatry at the University of Cincinnati, College of Medicine. He also is the CEO of University Managed Care, which has two operational units: Alliance Behavioral Care, a regional managed behavioral health care organization, and UC HealthPartners, a medical disease management company. Dr. Daniels also serves as executive director for University Psychiatric Services, a multidisciplinary behavioral group practice. All of these organizations are affiliated with the Department of Psychiatry at the University of Cincinnati. Dr. Daniels is active on a number of boards and professional organizations. In 2002 he chaired the American College of Mental Health Administration’s Annual Summit on Translating the Institute of Medicine’s Crossing the Quality Chasm Report for Behavioral Healthcare. He has participated in two Institute of Medicine committees, the committee on Crossing the Quality Chasm: Priority Areas for Health Care Improvement and the Committee on Crossing the Quality Chasm: Adaptation to Mental Health and Addictive Disorders. Dr. Daniels has published extensively in the areas of managed care and group practice operations, quality improvement and clinical outcomes, and academic health care. He has lectured and consulted both nationally and internationally on these subjects. He is a graduate of the University of Chicago School of Social Services Administration and the University of Cincinnati.

Kay Dickersin, M.A., Ph.D.
Kay Dickersin, PhD, Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, currently serves as Director of the United States Cochrane Center (USCC), one of 12 regional centers in the international Cochrane Collaboration. The Collaboration aims to help people make well informed decisions about health by preparing, maintaining, and promoting the accessibility of systematic reviews of available evidence on the benefits and risks of health care. From 1994 to 2005, the USCC coordinated development of the Cochrane Central Register of Controlled Trials, which includes over 470,000 controlled trials, most of them published. She has been a member of numerous IOM/NRC committees, including the Committee on Research in Education (2002-2004), the Committee on Reimbursement of Routine Patient Care Costs for Medicare Patients Enrolled in Clinical Trials (1998-1999), the Committee on Defense Women's Health Research (1996-1997), the Forum on Drug Development (1993-1995), and others. Dr. Dickersin received her BA and MA in zoology from the University of California at Berkeley and her PhD in epidemiology from the Johns Hopkins University School of Hygiene and Public Health in 1989.

Robert S. Galvin, M.D.
Robert S. Galvin, M.D., is the Director of Global Health Care for General Electric.  He is in charge of the design and performance of GE's health programs, totaling over $3B annually, and oversees the 1 million patient encounters that take place in GE's 220 medical clinics in over 20 countries.  Drawing on his clinical expertise and training in Six Sigma, Dr. Galvin has been an advocate and leader in extending the benefits of this methodology to healthcare.  Dr. Galvin has focused on issues of market-based health policy and financing, with a special interest in quality measurement, payment reform, and the payer role in medical innovations.  He is a past member of the Strategic Framework Board of the National Quality Forum and is currently on the Board of the National Committee for Quality Assurance as well as a member of the Hospital Quality Alliance.  He is a co-founder of the Leapfrog Group and founder of Bridges to Excellence, one of the first pay-for-performance initiatives.  Dr. Galvin is widely published on issues affecting the purchaser side of health care, and is Professor Adjunct of Medicine at Yale, where he directs the seminar series on the Private Sector for the Robert Wood Johnson Clinical Scholars fellowship.  He is a fellow of the American College of Physicians.

Dana P. Goldman, Ph.D.
Dana P. Goldman, Ph.D. holds the RAND Chair in Health Economics and is Director of the Peter Bing Center for Health Economics. He also is an Adjunct Professor of Radiology and Health Services at UCLA. Dr. Goldman's research combines applied economics with health care delivery, and has been published in the top medical, economic, statistics, and health policy journals.  He is on the editorial board of several research journals, including Health Affairs.  Research sponsors include the National Institutes on Health, the National Institute of Aging, the National Cancer Institute, the Department of Labor, the Center for Medicare and Medicaid Services, the Agency for Healthcare Research and Quality, the National Science Foundation, and the California HealthCare Foundation.  Dr. Goldman is a past recipient of the Alice S. Hersh New Investigator Award that recognizes the contribution of young scholars to the field of health services research.  He also received the National Institute for Health Care Management Research and Educational Foundation award for excellence in health policy. Dr. Goldman is a Research Associate with the National Bureau of Economic Research and Director of the UCLA/RAND Postdoctoral Health Services Research Training Program. He received his Ph.D. in Economics from Stanford University and a B.A summa cum laude in Economics from Cornell University.

Richard A. Justman, M.D.
Richard Justman, M.D., is national medical director of UnitedHealthcare, a national health service delivery company.  He works in the Clinical Advancement division. Dr. Justman is accountable for medical technology assessment, clinical support of pharmacy programs and clinical support of benefit administration.  He has been with UnitedHealthcare since 1993.  Dr. Justman received his bachelor’s degree from Cornell University and his MD degree from the State University of New York at Buffalo. He is board-certified in pediatrics, and received his postgraduate training at The University of Chicago Hospitals and Clinics and the Johns Hopkins Hospital.  Dr. Justman practiced pediatrics in Minneapolis, Minnesota for fifteen years before joining UnitedHealthcare.

Arthur A. Levin, M.P.H.
Arthur A. Levin is Director of the Center for Medical Consumers, a New York City based non-profit organization committed to informed consumer and patient health care decision-making, patient safety, evidence-based, high quality medicine and health care system transparency.  The Center publishes a monthly newsletter HealthFacts, which offers a critique of medical and health practices based on the available scientific evidence and expert opinion. Mr. Levin was a member of the Institute of Medicine’s Committee on the Quality of Health Care that published the To Err is Human and Crossing the Quality Chasm reports. He also served as a member of the Institute of Medicine committee that evaluated the federal quality effort and made recommendations to Congress in its report Leadership By Example. Mr. Levin spent more than 10 years as a public member of an Institution Review Board at a New York State hospital and research center aligned with a large academic medical center. He also was a member of a Department of Health task force that reviewed special concerns about research and healthy normal volunteers. He is currently a member of the FDA’s Consumer Nominating Workgroup that recommends consumer representatives for FDA Advisory Committees and of the NYS Department of Health statewide workgroup that has redesigned the state’s hospital incident reporting and adverse event tracking system known as NYPORTS. Mr. Levin has also served as a guest expert on risk management at several FDA Drug Advisory Committee meetings and currently serves as the consumer member on the FDA’s Drug Safety and Risk Management Advisory Committee (DSaRM).  Mr. Levin is a member of the Committee on Performance Measures of the National Committee for Quality Assurance (NCQA) and several National Quality Forum Measure Maintenance Committees. He earned his Masters of Public Health degree from Columbia University School of Public Health and his Bachelor of Arts degree in Philosophy from Reed College.

Richard E. Marshall, M.D.
Richard Marshall, M.D., is the former Chief Medical Officer and a practicing pediatrician at Harvard Vanguard Medical Associates, a multispecialty medical group of 500 physicians serving 300,000 patients at 16 offices in the Boston area. He currently leads the group’s research efforts. Dr. Marshall is a Phi Beta Kappa graduate of Stanford University. After earning his medical degree from the University of California-San Diego School of Medicine in 1973, he went on to earn an M.S. in nutritional biochemistry at the Massachusetts Institute of Technology. Dr. Marshall was board certified in pediatrics in 1980. He currently serves on the Board of Directors of the community-based organizations: Fenway Community Health, a community health center and research organization in Boston known for its work on HIV care and prevention and Massachusetts Health Quality Partners, an organization currently focused on public release of quality and patient care experience data.  He is also a member of the Massachusetts commission on Gay and Lesbian youth.

Wilhelmine Miller, M.S., Ph.D.
Wilhelmine Miller, M.S., Ph.D., is an associate research professor at the George Washington University School of Public Health and Health Services. Between 1999 and 2006  she was a senior program officer at the IOM, serving as staff director for the committee that authored Valuing Health for Regulatory Cost-Effectiveness Analysis and as co-director of the four-year study on the consequences of uninsurance. Dr. Miller has been an adjunct faculty member in the Departments of Philosophy at Georgetown University and Trinity College, Washington, DC, where she taught political philosophy, ethics, and public policy. She received her doctorate in philosophy from Georgetown in 1997. From 1976–1989 Dr. Miller served as a policy analyst and social scientist within the Department of Health and Human Services. She received her M.S. degree in health policy and management from Harvard University in 1976.

Sally C. Morton, Ph.D.
Dr. Sally C. Morton joined RTI in 2005 as Vice President for Statistics and Epidemiology, and leads a unit of 225 statisticians, epidemiologists, psychometricians, and associated scientists and staff.  Previously, Dr. Morton was Head of the RAND Corporation Statistics Group from 1995 to 2002 and held the RAND Endowed Chair in Statistics from 2000 to 2005.  From 1997 to 2005 she was Co-Director of the Southern California Evidence-based Practice Center funded by the Agency for Healthcare Research and Quality (AHRQ).  At the RAND Corporation, she also was Principal Investigator of the Medicare Stop Smoking Program, Co-Principal Investigator of the AHRQ Patient Safety Program Evaluation Center, and the Data and Analysis Task Leader on the HIV Costs and Services Utilization Study (HCSUS).  She held a variety of leadership and statistical roles on numerous other health services projects.  Her methodological interests include the use of meta-analysis in evidence-based medicine, the sampling of vulnerable populations, and statistical methods for health services research.  Dr. Morton was a member of the faculty of the Pardee RAND Graduate School, taught at the UCLA School of Public Health, and was an adjunct professor at the USC Marshall School of Business.  She is an editor of Statistical Science and served as an associate editor for the Journal of the American Statistical Association and the Journal of Computational and Graphical Statistics.  She serves on the National Institute of Statistical Sciences Executive Committee and is a member of the Educational Testing Service’s Data Advisory Committee for the National Assessment of Educational Progress (NAEP).  She was a member of the National Academy of Sciences Panel on small-area estimation of school-age children in poverty.  Dr. Morton is a Fellow of the American Statistical Association and of the American Association for the Advancement of Science.  She received a Ph.D. in statistics from Stanford University.

Sam Nussbaum, M.D.
Dr. Samuel Nussbaum is executive vice president and chief medical officer for WellPoint, Inc. He oversees corporate medical policy, clinical pharmacy programs, health improvement and quality resources, transplant management program strategy, disease and care management strategy, and clinical informatics to optimize care for members.  Dr. Nussbaum is immediate past president of the Disease Management Association of America, served as Chairman of the National Committee for Quality Health Care, and serves as Chair of America's Health Insurance Plan's (AHIP) Chief Medical Officer Leadership Council and serves on the AHIP Board. He received the 2004 Physician Executive Award of Excellence from the American College of Physician Executives and Modern Physician magazine. He is also the chairman of the Health Care Data and Quality Subcommittee of the Indiana Commission on Excellence in Health Care.  Dr. Nussbaum served as executive vice president, Medical Affairs and System Integration, of the BJC Health System-one of the largest academic and community integrated health and hospital systems in the United States, where he also served as CEO of its health plan and president of its medical group.  Dr. Nussbaum earned his medical degree from Mount Sinai School of Medicine. He trained in internal medicine at Stanford and Harvard and in endocrinology and metabolism at Harvard and Massachusetts General Hospital.  Dr. Nussbaum is board-certified in internal medicine and specialty certified in endocrinology and metabolism.

Diana B. Petitti, M.D., M.P.H.
Diana B. Petitti, MD, MPH, is the Adjunct Professor, Department of Preventive Medicine, University of Southern California, Keck School of Medicine. She is also the Vice Chair of the U.S. Preventive Services Task Force. Dr. Petitti served on the National Cancer Policy Board (1997 - 2003), including as co-chair, the Board on Population Health and Public Health Practice (1995-1997), and has co-chaired three IOM committees (Committee on New Approaches to Early Detection of Breast Cancer: Accelerating the Flow from Concept to Clinic; Committee on Large-Scale Science and Cancer Research; and the Committee on Cancer Survivorship: Improving Care and Quality of Life After Treatment). Dr. Petitti is a graduate of Cornell University with a bachelors of arts degree with distinction in all subjects. She earned her MD from Harvard Medical School in 1975. After an internship in Medicine at the University of Colorado Affiliated Hospitals, she spent two years as an Epidemic Intelligence Service Officer with the Centers for Disease Control. She received her Masters in Public Health from the University of California Berkeley School of Public Health in 1981. Dr. Petitti was board certified in preventive medicine in 1981 and has done extensive research on the role of hormones and disease, and on the application of the principles of evidence-based medicine. Dr. Petitti is a member of the American Public Health Association, the Society for Epidemiologic Research, the American Epidemiologic Society and is a Fellow of the American Heart Association Council on Epidemiology. She serves on the editorial board of American Journal of Preventive Medicine. She is currently a member of the California Office of Statewide Planning on Health Technical Advisory Committee. Dr. Petitti has authored two books and more than 200 scientific publications. She has served as a member of many national committees providing advice on issues of health and health policy.

Steven Shak, M.D.
Steven Shak, M.D., is Chief Medical Officer of Genomic Health, Inc, which is focused on improving the quality of treatment decisions for cancer patients. He and his colleagues have worked together with leading oncology clinical research groups in the United States to use new molecular diagnostic methods and rigorous clinical studies to develop the Oncotype DXTM breast cancer assay. Dr. Shak has previously served as Senior Director and Staff Clinical Scientist at Genentech, Inc. where he led the clinical team that gained approval for trastuzumab (Herceptin®), a targeted biologic treatment for metastatic breast cancer. He also initiated the cancer clinical trials of the anti-angiogenesis agent, bevacizumab (Avastin®). In addition, Dr. Shak discovered dornase alfa (Pulmozyme®), a mucus-dissolving enzyme that is approved worldwide for the treatment of the genetic disease, cystic fibrosis. Dr. Shak has also held faculty positions at the New York University School of Medicine and Bellevue Hospital from 1978 to 1986. Throughout his career in academia and industry he has focused not only on the science and medicine of drug, device, and diagnostic development but also on the public health issues of access, cost, and appropriate use of expensive new technologies. Dr. Shak served on the Board of an independent, non-profit endowment dedicated to expanding access to Pulmozyme therapy to qualifying uninsured and underinsured cystic fibrosis patients. He also participated in establishing a multicenter epidemiologic study of the natural history of cystic fibrosis to describe practice patterns of cystic fibrosis care givers and to identify prognostic factors for morbidity and mortality. Dr. Shak has collaborated in drug development with many patient advocacy organizations. He is currently on the Board of Directors of The Children’s Cause for Cancer Advocacy, a pediatric cancer advocacy organization. Dr. Shak has received numerous awards and honors for his contributions to medicine and patient care. Dr. Shak has an undergraduate degree from Amherst College, an MD degree from New York University School of Medicine, and post graduate training in medicine and research at Bellevue Hospital in New York City and the University of California, San Francisco.

Lisa Simpson, M.B., B.Ch., M.P.H., F.A.A.P.
Dr. Simpson is Professor of Pediatrics, Public Health and Nursing and holds the ACH Guild Endowed Chair in Child Health Policy at All Children's Hospital and the University of South Florida, Department of Pediatrics. Dr. Simpson, a board-certified pediatrician, is the National Director for Child Health Policy at the National Initiative for Children’s Healthcare Quality, an education and research organization dedicated solely to improving the quality of health care provided to children. She is a former Deputy Director of the Agency for Healthcare Research and Quality and was the Maternal and Child Health Director in Hawaii. Dr. Simpson earned her undergraduate and medical degrees at Trinity College (Dublin) and a Masters in Public Health at the University of Hawaii. She has received numerous awards including the Excellence in Public Service Award from the American Academy of Pediatrics, the Senior Executive Service Meritorious Presidential Rank Award, and the DHHS Secretary's Distinguished Service Award for the development of a user-driven and integrated planning, budget and evaluation strategy for the Agency.

Glenn D. Steele, Jr., M.D., Ph.D.
Dr. Steele became President and Chief Executive Officer of the Geisinger Health System in 2001. In this capacity, he serves as a member of the Geisinger Health System Foundation Board of Directors, ex-officio of all Standing Committees of the Board and Chairman of the subsidiary boards.  Dr. Steele joined Geisinger from the University of Chicago where he served as the Richard T. Crane Professor in the Department of Surgery, Vice President for Medical Affairs and Dean of the Division of Biological Sciences and the Pritzker School of Medicine.  Prior to that, he was the William V. McDermott Professor of Surgery at Harvard University Medical School, Chairman of the Department of Surgery of New England Deaconess Hospital, and President and Chief Executive Officer of Deaconess Professional Practice Group.  Dr. Steele is widely recognized for his investigations into the treatment of primary and metastatic liver cancer and colorectal cancer surgery. He is a past Chairman of the American Board of Surgery and serves on the editorial boards of numerous prominent medical journals.  His laboratory investigations have focused on the cell biology of gastrointestinal cancer and pre-cancer. A prolific writer, he is the author or co-author of more than 450 scientific and professional articles.  Dr. Steele is a member of the Institute of Medicine of the National Academy of Sciences, the New England Surgical Society, a fellow of the American College of Surgeons, the American Surgical Association, the American Society of Clinical Oncology, Society of Surgical Oncologists, The Commonwealth Fund, Healthcare Executive Network, the U.S. Department of Health's National Advisory Committee on Rural Health, and the Center of Corporate Innovation (CCI). He serves on the American Hospital Association Health Care Systems Governing Council and the AHA Strategic Policy Planning and Hospital/Medical Staff Committees. Dr. Steele received his BA degree in history from Harvard College and his MD degree from New York University School of Medicine. He completed his internship and residency in surgery at the University of Colorado, where he was also a Fellow of the American Cancer Society. He earned his Ph.D. degree in microbiology at Lund University in Sweden.